SLC6A3 and SLC6A3-related dopamine transporter deficiency syndrome: The diagnosis of DTDS is confirmed by either biallelic loss-of-function pathogenic variants in SLC6A3 or heterozygous dominant-negative SLC6A3 pathogenic variants known to cause autosomal dominant DTDS [10].